The nutrients available from seafood could drop by 30 per cent for low-income countries by the end of the century due to climate change, suggests new UBC research.
Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year
Seven months after Nimbus Therapeutics sold an experimental autoimmune disease medicine to Takeda Pharmaceuticals for up to $6 billion, the Boston biotech said Wednesday it has raised
September 6, 2023